Advisory Committee on Immunization Practices (ACIP), 10490 [2017-02879]
Download as PDF
<![CDATA[
10490
Federal Register / Vol. 82, No. 28 / Monday, February 13, 2017 / Notices
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
AGENCY:
[FR Doc. 2017–02878 Filed 2–10–17; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
jstallworth on DSK7TPTVN1PROD with NOTICES
Advisory Committee on Immunization
Practices (ACIP)
Correction: This notice was published
in the Federal Register on January 25,
2017, Volume 82, Page 8427. The
Matters for Discussion should read as
follows:
Matters for Discussion: The agenda
will include discussions on:
Meningococcal vaccine; influenza;
hepatitis B vaccine; herpes zoster
vaccine; vaccine safety; yellow fever
vaccine; Zika virus vaccine; mumps
outbreak; Dengue virus vaccines; Polio
Eradication Initiative; Measles and
Rubella Elimination Initiative; adult
immunization and vaccine supply. A
recommendation vote is scheduled for
hepatitis B vaccine A Vaccines for
Children (VFC) vote is scheduled for
hepatitis B vaccine.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Stephanie Thomas, National Center for
Immunization and Respiratory Diseases,
CDC, 1600 Clifton Road NE., MS–A27,
Atlanta, Georgia 30329, telephone 404/
639–8836; Email ACIP@CDC.GOV.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
BILLING CODE 4163–18–P
VerDate Sep<11>2014
13:41 Feb 10, 2017
Jkt 241001
Meeting of the Advisory Committee on
Training in Primary Care Medicine and
Dentistry
Health Resources and Service
Administration (HRSA), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
In accordance with the
Federal Advisory Committee Act, notice
is hereby given that a meeting is
scheduled for the Advisory Committee
on Training in Primary Care Medicine
and Dentistry (ACTPCMD). This
meeting will be open to the public.
Information about ACTPCMD and the
agenda for this meeting can be obtained
by accessing the ACTPCMD Web site at
https://www.hrsa.gov/
advisorycommittees/bhpradvisory/
ACTPCMD.
SUMMARY:
BILLING CODE 4163–18–P
[FR Doc. 2017–02879 Filed 2–10–17; 8:45 am]
Health Resources and Services
Administration
March 6, 2017, 9:00 a.m.–5:00
p.m. ET and March 7, 2017, 8:30 a.m.–
5:00 p.m. ET
ADDRESSES: This meeting will be held in
person and offer virtual access through
teleconference and webinar. The
address for the meeting is 5600 Fishers
Lane, Rockville, Maryland 20857.
• The conference call-in number is 1–
800–619–2521. Passcode: 9271697.
• The webinar link is https://
hrsa.connectsolutions.com/actpcmd.
Status: This advisory committee
meeting will be open to the public.
FOR FURTHER INFORMATION CONTACT:
Anyone requesting information
regarding ACTPCMD should contact Dr.
Kennita Carter, Designated Federal
Official, Division of Medicine and
Dentistry, Bureau of Health Workforce,
HRSA, in one of three ways: (1) Send a
request to the following address: Dr.
Kennita Carter, Designated Federal
Official, Division of Medicine and
Dentistry, HRSA, 5600 Fishers Lane,
15N–116, Rockville, Maryland 20857;
(2) call 301–945–3505; or (3) send an
email to KCarter@hrsa.gov.
SUPPLEMENTARY INFORMATION: The
ACTPCMD provides advice and
recommendations to the Secretary of
HHS (Secretary) on policy, program
development, and other matters of
significance concerning the activities
under sections 747 and 748 of title VII
of the Public Health Service Act (PHS
Act). The ACTPCMD prepares an annual
report describing the activities of the
Committee, including findings and
recommendations made by the
DATES:
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
Committee regarding the activities
under sections 747 and 748. The annual
report is submitted to the Secretary, and
Chairmen and ranking members of the
Senate Committee on Health, Education,
Labor and Pensions and the House of
Representatives Committee on Energy
and Commerce. The Committee also
develops, publishes, and implements
performance measures and guidelines
for longitudinal evaluations for
programs authorized under Part C of
Title VII of the PHS Act, and
recommends appropriation levels for
programs under this Part.
During the March 6–7, 2017 meeting,
the ACTPCMD will discuss issues
related to the Committee report on the
integration of behavioral health into
primary care and oral health training;
and clinical trainee and faculty wellbeing and resiliency. Agenda items are
subject to change.
Members of the public will have the
opportunity to provide comments.
Public participants may submit written
statements in advance of the scheduled
meeting. Oral comments will be
honored in the order they are requested
and may be limited as time allows.
Requests to make oral comments or
provide written comments to the
ACTPCMD should be sent to Dr.
Kennita Carter, Designated Federal
Official, using the contact information
above at least 3 business days prior to
the meeting.
The 5600 Fishers Lane building
requires a security screening on entry.
To facilitate your access to the building,
please contact Dr. Kennita Carter at the
contact information listed above.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify Dr. Kennita Carter at least 10 days
prior to the meeting.
Jason E. Bennett,
Director, Division of the Executive Secretariat.
[FR Doc. 2017–02833 Filed 2–10–17; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
E:\FR\FM\13FEN1.SGM
13FEN1
]]>Agencies
[Federal Register Volume 82, Number 28 (Monday, February 13, 2017)]
[Notices]
[Page 10490]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-02879]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee on Immunization Practices (ACIP)
Correction: This notice was published in the Federal Register on
January 25, 2017, Volume 82, Page 8427. The Matters for Discussion
should read as follows:
Matters for Discussion: The agenda will include discussions on:
Meningococcal vaccine; influenza; hepatitis B vaccine; herpes zoster
vaccine; vaccine safety; yellow fever vaccine; Zika virus vaccine;
mumps outbreak; Dengue virus vaccines; Polio Eradication Initiative;
Measles and Rubella Elimination Initiative; adult immunization and
vaccine supply. A recommendation vote is scheduled for hepatitis B
vaccine A Vaccines for Children (VFC) vote is scheduled for hepatitis B
vaccine.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Stephanie Thomas, National
Center for Immunization and Respiratory Diseases, CDC, 1600 Clifton
Road NE., MS-A27, Atlanta, Georgia 30329, telephone 404/639-8836; Email
ACIP@CDC.GOV.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2017-02879 Filed 2-10-17; 8:45 am]
BILLING CODE 4163-18-P
